Metraipolis › archive › dc_f78ecc2df041

Integrated Genetic Screening Identifies FEN1 as a Selective Vulnerability and Temozolomide Resistance Mediator in Glioblastoma Stem Cells — Europe PMC PMID:42770249

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42770249
DOI
10.1158/2767-9764.crc-26-0150
License (as archived)
solo-consultazione
Archived
2026-10-16T16:40:41.845Z
SHA-256 of the archived text
2b213bc831b6777d42d8854b15c04f34bfa06819cd126d06499ba7036705c75d
Stable URL of this page
https://metraipolis.com/documento/dc_f78ecc2df041

How to cite

Integrated Genetic Screening Identifies FEN1 as a Selective Vulnerability and Temozolomide Resistance Mediator in Glioblastoma Stem Cells — Europe PMC PMID:42770249 — Europe PMC (en), https://europepmc.org/article/MED/42770249 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f78ecc2df041 (Metraipolis archive dc_f78ecc2df041, sha256 2b213bc831b6777d42d8854b15c04f34bfa06819cd126d06499ba7036705c75d)
BibTeX
@misc{dcf78ecc2df041,
  title = {Integrated Genetic Screening Identifies FEN1 as a Selective Vulnerability and Temozolomide Resistance Mediator in Glioblastoma Stem Cells — Europe PMC PMID:42770249},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42770249},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f78ecc2df041; sha256 2b213bc831b6777d42d8854b15c04f34bfa06819cd126d06499ba7036705c75d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42770249. Agents can read the archived copy with the MCP tool read_document.